Literature DB >> 11012220

The platelet glycoprotein Ib-V-IX system: regulation of gene expression.

G J Roth1, M Yagi, L S Bastian.   

Abstract

Platelet glycoproteins (GPs) Ib-V-IX form the surface receptor for von Willebrand factor, and this receptor-ligand interaction mediates the shear-dependent adhesion of platelets to damaged arterial vessel walls. The receptor is a multicomponent structure consisting of four distinct polypeptides (heterodimeric GPIb: Ib alpha-Mr143k and Ib beta-Mr22k; GPV-Mr83k; GPIX-Mr20k), and each of the four cDNAs and genes has been cloned and characterized. The genes appear to have evolved from a common progenitor genomic sequence related to that encoding GPIX. They share simple structures with few introns and possess common consensus regulatory sequences (GATA, ets, Sp-1) in their 5' flanks. Both the GPIb alpha and the GPIX promoters have been analyzed by transfection of reporter constructs into hematopoietic and nonhematopoietic cells. The promoters function in a tissue-specific fashion, and gel shift and mutational analyses indicate that GATA and ets sequences regulate activity. In the case of the GPIX promoter, footprints confirm the role of the ets-related consensus region. Recent studies of GPIb beta transcriptional regulation suggest that an aberrant polyadenylation signal, located in the 3' end of the gene immediately upstream of the GPIb beta gene, allows in vitro expression of a rare extended fusion transcript encoding both the upstream protein and GPIb beta. Little detailed information is available in regard to expression of the GPV gene. In summary, the genes of the GPIb-V-IX system display features of other megakaryocyte/platelet genes, but the unique regulatory events that direct the selective expression of these genes in megakaryocytes remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11012220     DOI: 10.1002/stem.5530140724

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  8 in total

1.  Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins.

Authors:  Liyan Pang; Hai-Hui Xue; Gabor Szalai; Xun Wang; Yuhuan Wang; Dennis K Watson; Warren J Leonard; Gerd A Blobel; Mortimer Poncz
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 2.  Historical review: megakaryopoiesis and thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

Review 3.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

Review 4.  Megakaryocyte- and megakaryocyte precursor-related gene therapies.

Authors:  David A Wilcox
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

5.  Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

Authors:  Juan Fang; Kairbaan Hodivala-Dilke; Bryon D Johnson; Lily M Du; Richard O Hynes; Gilbert C White; David A Wilcox
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

6.  Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling.

Authors:  Brenda Lilly; Simone Kennard
Journal:  Physiol Genomics       Date:  2008-11-04       Impact factor: 3.107

7.  Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein.

Authors:  Paul A Reynolds; Gromoslaw A Smolen; Rachel E Palmer; Dennis Sgroi; Vijay Yajnik; William L Gerald; Daniel A Haber
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

Review 8.  Pathobiology of secondary immune thrombocytopenia.

Authors:  Douglas B Cines; Howard Liebman; Roberto Stasi
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.